Cefuroxime (2nd Gen) Tablets/Capsules bulk supplier for pharma manufacturers

Cefuroxime (2Nd Gen) Tablets/Capsules 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets/Capsules

Available Strengths: 250 mg, 500 mg

Reference Brands: Ceftin, Zinacef(US & EU)

Cefuroxime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against respiratory, urinary, skin, and soft tissue infections. Benefits include broad-spectrum activity, rapid bacterial eradication, and oral administration, making it a reliable choice for treating common bacterial infections when used appropriately.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Cefuroxime (2nd generation cephalosporin) tablets and capsules are approved in both the EU and US for treating respiratory, urinary, and skin bacterial infections. In the EU, brands like Ceftin and Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans. For regulatory support, compliance, and registration, visit PharmaTradz. We support seamless market access for cefuroxime, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Cefuroxime (2Nd Gen) Tablets/Capsules — third party manufacturing & bulk supply

Cefuroxime (2Nd Gen) Tablets/Capsules 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefuroxime (2Nd Gen) Tablets/Capsules is supplied as Oral Tablets/Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefuroxime (2Nd Gen) Tablets/Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefuroxime (2Nd Gen) Tablets/Capsules →

Back to Listing

Frequently Asked Questions

Cefuroxime (2nd Gen) Tablets/Capsules is listed as Oral Tablets/Capsules in 250 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefuroxime (2nd Gen) Tablets/Capsules is referenced against Ceftin, Zinacef(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.